These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Heterologous specific antiserum for identification of human T lymphocytes.
    Author: Touraine JL, Touraine F, Kiszkiss DF, Choi YS, Good RA.
    Journal: Clin Exp Immunol; 1974 Apr; 16(4):503-20. PubMed ID: 4143194.
    Abstract:
    Peripheral blood lymphocytes (PBL) from two patients with Bruton-type agammaglobulinaemia were used for the preparation of heterologous anti-human T cell-sera which were absorbed with cultured B lymphoblast cells, peripheral blood lymphocytes from a patient with chronic lymphatic leukaemia and `adherent' cells. Using multiple criteria, one antiserum (ATCS) was shown to be specific for T lymphocytes. This antiserum asserts the existence of human-specific T-lymphocyte antigen(s) (HTLA) and provides another method for identifying human T cells. In the presence of rabbit complement, ATCS was cytotoxic for 65·5% (range 49–78) of normal PBL and 97% of thymocytes (the latter cells having also a higher surface density of HTLA than PBL). The study of PBL from a variety of patients showed that the percentage of ATCS-sensitive cells was high in Bruton-type agammaglobulinaemia, variable from patient to patient and from time to time in common variable hypogammaglobulinaemia and generally low in active lepromatous leprosy, in patients under antilymphocyte globulin therapy and in chronic lymphatic leukaemia. Cultured lymphoblasts from various B cell lines or from a Burkitt lymphoma cell line were resistant to ATCS.
    [Abstract] [Full Text] [Related] [New Search]